Author:
King Jonathan C.,Zenati Mazen,Steve Jennifer,Winters Sharon B.,Bartlett David L.,Zureikat Amer H.,Zeh Herbert J.,Hogg Melissa E.
Publisher
Springer Science and Business Media LLC
Reference24 articles.
1. Howlader N, Noone AM, Krapcho M, et al (eds). SEER Cancer Statistics Review, 1975–2011, National Cancer Institute. Bethesda, MD,
http://seer.cancer.gov/csr/1975_2011/
, based on November 2013 SEER data submission, posted to the SEER web site, April 2014.
2. American Cancer Society. Cancer Facts & Figures 2015. Atlanta: American Cancer Society; 2015.
3. Winter JM, Brennan MF, Tang LH, et al. Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades. Ann Surg Oncol. 2012;19:169-75.
4. Conroy T, Desseigne F, Ychou M, et al. FOLFIRINOX versus gemcitabine for metastatic pancreatic cancer. N Engl J Med. 2011;364:1817-25.
5. Von Hoff DD, Ervin T, Arena FP, et al. Increased survival in pancreatic cancer with nab-Paclitaxel plus gemcitabine. N Engl J Med. 2013;369:1691-703.
Cited by
31 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献